Literature DB >> 16321974

Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses.

Raymond Cheong1, Adriel Bergmann, Shannon L Werner, Joshua Regal, Alexander Hoffmann, Andre Levchenko.   

Abstract

Dynamic properties of signaling pathways control their behavior and function. We undertook an iterative computational and experimental investigation of the dynamic properties of tumor necrosis factor (TNF)alpha-mediated activation of the transcription factor NF-kappaB. Surprisingly, we found that the temporal profile of the NF-kappaB activity is invariant to the TNFalpha dose. We reverse engineered a computational model of the signaling pathway to identify mechanisms that impart this important response characteristic, thus predicting that the IKK activity profile must transiently peak at all TNFalpha doses to generate the observed NF-kappaB dynamics. Experimental confirmation of this prediction emphasizes the importance of mechanisms that rapidly down-regulate IKK following TNFalpha activation. A refined computational model further revealed signaling characteristics that ensure robust TNFalpha-mediated cell-cell communication over considerable distances, allowing for fidelity of cellular inflammatory responses in infected tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16321974     DOI: 10.1074/jbc.M510085200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Evidence-based modeling of critical illness: an initial consensus from the Society for Complexity in Acute Illness.

Authors:  Yoram Vodovotz; Gilles Clermont; C Anthony Hunt; Rolf Lefering; John Bartels; Ruediger Seydel; John Hotchkiss; Shlomo Ta'asan; Edmund Neugebauer; Gary An
Journal:  J Crit Care       Date:  2007-03       Impact factor: 3.425

Review 2.  Wires in the soup: quantitative models of cell signaling.

Authors:  Raymond Cheong; Andre Levchenko
Journal:  Trends Cell Biol       Date:  2008-02-21       Impact factor: 20.808

3.  High content cell screening in a microfluidic device.

Authors:  Raymond Cheong; Chiaochun Joanne Wang; Andre Levchenko
Journal:  Mol Cell Proteomics       Date:  2008-10-24       Impact factor: 5.911

Review 4.  Integrating computational and biochemical studies to explore mechanisms in NF-{kappa}B signaling.

Authors:  Jeffrey D Kearns; Alexander Hoffmann
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

5.  NF-kappaB dictates the degradation pathway of IkappaBalpha.

Authors:  Erika Mathes; Ellen L O'Dea; Alexander Hoffmann; Gourisankar Ghosh
Journal:  EMBO J       Date:  2008-04-10       Impact factor: 11.598

6.  Tunable signal processing through a kinase control cycle: the IKK signaling node.

Authors:  Marcelo Behar; Alexander Hoffmann
Journal:  Biophys J       Date:  2013-07-02       Impact factor: 4.033

Review 7.  Ubiquitination and degradation of the inhibitors of NF-kappaB.

Authors:  Naama Kanarek; Nir London; Ora Schueler-Furman; Yinon Ben-Neriah
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 8.  Encoding and decoding cellular information through signaling dynamics.

Authors:  Jeremy E Purvis; Galit Lahav
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

9.  Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling.

Authors:  Britney L Moss; Shimon Gross; Seth T Gammon; Anant Vinjamoori; David Piwnica-Worms
Journal:  J Biol Chem       Date:  2008-01-17       Impact factor: 5.157

10.  Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20.

Authors:  Shannon L Werner; Jeffrey D Kearns; Victoria Zadorozhnaya; Candace Lynch; Ellen O'Dea; Mark P Boldin; Averil Ma; David Baltimore; Alexander Hoffmann
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.